Exclusive Online Content
Aptar Pharma's Preservative-Free Multidose Dispenser Chosen for the First Time
Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the US prescription market for the first time with Allergan’s…
Nemera Wins Editor's Choice Category at INTERPHEX Awards for Safelia®
International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization and sponsored by the Parenteral…
Nemera Wins Editor's Choice Category at INTERPHEX Awards for Safelia®
International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization and sponsored by the Parenteral…
Alcami Introduces Seamless Customer Experience With New Customer Portal & Application, Alcami OnDemand™
Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, is setting the industry standard for project management and…
Alcami Introduces Seamless Customer Experience With New Customer Portal & Application, Alcami OnDemand™
Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, is setting the industry standard for project management and…
Pfizer CentreOne Adds Highly Potent Solid Oral Dose to its Service Portfolio
Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, recently announced that it has grown its service portfolio to include contract manufacturing of…
Pfizer CentreOne Adds Highly Potent Solid Oral Dose to its Service Portfolio
Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, recently announced that it has grown its service portfolio to include contract manufacturing of…
ABITEC Corporation & IMCD Announce Specialty Lipid Distribution Agreement
US ingredients conglomerate announces new partnership to distribute specialty lipids into the pharmaceutical and nutritional markets in Asia and South America. ABITEC Corporation has…
Avomeen Analytical Services Announces New CEO
Avomeen Analytical Services, a full-service independent analytical testing and product development laboratory based in Ann Arbor, MI, recently announced that Mark Harvill has been named…
ABITEC Corporation & IMCD Announce Specialty Lipid Distribution Agreement
US ingredients conglomerate announces new partnership to distribute specialty lipids into the pharmaceutical and nutritional markets in Asia and South America. ABITEC Corporation has…
$100 Billion of Revenues up for Grabs for Drug Manufacturers by 2020 as Patents for Key Biologics Expire
Although complexities inherent in biological drug manufacturing are creating barriers for further expansion of the biosimilars market, imminent patent expiries of key biologics are set…
$100 Billion of Revenues up for Grabs for Drug Manufacturers by 2020 as Patents for Key Biologics Expire
Although complexities inherent in biological drug manufacturing are creating barriers for further expansion of the biosimilars market, imminent patent expiries of key biologics are set…
Ompi EZ-Fill Becomes an Internationally Recognized Standard Platform for RTU Sterile Containers
Ompi, the company within Stevanato Group specialized in glass primary packaging for the pharmaceutical industry, has signed a license agreement with Gerresheimer. The agreement…
Ompi EZ-Fill Becomes an Internationally Recognized Standard Platform for RTU Sterile Containers
Ompi, the company within Stevanato Group specialized in glass primary packaging for the pharmaceutical industry, has signed a license agreement with Gerresheimer. The agreement…
Head & Neck Cancer Market Offers Fertile Investment Ground as Disease Understanding Improves
A substantial number of first-in-class products in the head and neck cancer pipeline will reach the market over the coming decade, potentially transforming the clinical…
Accelerating Development of Enabled Formulations for Poorly Soluble Drugs
Efficacy issues due to inadequate gastrointestinal (GI) absorption caused by insufficient aqueous solubility are encountered in up to 70% of new drugs in development. Often…
Capnia Completes Merger With Essentialis, Creating Rare Disease Therapeutics Company
Capnia, Inc., focused on the development and commercialization of novel therapeutics for the treatment of rare diseases, recently announced it has completed its previously announced…
Head & Neck Cancer Market Offers Fertile Investment Ground as Disease Understanding Improves
A substantial number of first-in-class products in the head and neck cancer pipeline will reach the market over the coming decade, potentially transforming the clinical…
Accelerating Development of Enabled Formulations for Poorly Soluble Drugs
Efficacy issues due to inadequate gastrointestinal (GI) absorption caused by insufficient aqueous solubility are encountered in up to 70% of new drugs in development. Often…
Capnia Completes Merger With Essentialis, Creating Rare Disease Therapeutics Company
Capnia, Inc., focused on the development and commercialization of novel therapeutics for the treatment of rare diseases, recently announced it has completed its previously announced…
